We thank Dr. Taha for his editorial on our article.1, 2 As discussed by Dr. Taha in a recent article for the British Society of Gastroenterology, the risk of NSAID-induced gastrointestinal damage should be addressed during long-term NSAID treatment, and we compliment Dr. Taha for emphasising the potential of a safe dietary supplement such as the probiotic strain Bifidobacterium breve Bif195 (DSM 33360), for aspirin users.3 We agree that alternative treatment strategies that may enable safe continuous NSAID treatment are warranted.